APA (7th ed.) Citation

J, H., Y, J., H, B., Y, I., M, K., T, I., . . . T, S. (2024). Potential Usefulness of Lifetime Globotriaosylsphingosine Exposure at Diagnosis and Baseline Modified Disease Severity Score in Early-Diagnosed Patients With Fabry Disease. Cureus, 16(5), e61380. https://doi.org/10.7759/cureus.61380

Chicago Style (17th ed.) Citation

J, Hotta, Jogu Y, Bamba H, Izumiya Y, Kudo M, Imai T, Sakuraba H, Hamazaki T, and Seto T. "Potential Usefulness of Lifetime Globotriaosylsphingosine Exposure at Diagnosis and Baseline Modified Disease Severity Score in Early-Diagnosed Patients With Fabry Disease." Cureus 16, no. 5 (2024): e61380. https://doi.org/10.7759/cureus.61380.

MLA (9th ed.) Citation

J, Hotta, et al. "Potential Usefulness of Lifetime Globotriaosylsphingosine Exposure at Diagnosis and Baseline Modified Disease Severity Score in Early-Diagnosed Patients With Fabry Disease." Cureus, vol. 16, no. 5, 2024, p. e61380, https://doi.org/10.7759/cureus.61380.